{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:38:44Z","timestamp":1792132724945,"version":"4.4.0"},"reference-count":154,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet sex-specific risk factors are usually not included in conventional predictive models. Specifically, heart failure (HF) in women may be influenced by sex-specific hormones and pathologies that need to be addressed to improve prevention and treatment.<\/jats:p>\n                  <jats:p>This expert consensus statement aims to provide a comprehensive roadmap for HF prevention and management across specific conditions affecting women during their life-course. Each section focuses on the impact of a specific female condition on CVD and how to prevent and manage HF in specific settings: (i) Pregnancy with a specific focus on how to deal with hypertensive disorders in the acute and chronic setting and how to prevent and treat peripartum cardiomyopathy; (ii) gynaecological conditions predisposing to HF, such as polycystic ovary syndrome, endometriosis, and the menopausal transition. Emphasis is placed on chronic inflammation, metabolic dysfunction, and the \u2018window of opportunity\u2019 for menopausal hormone therapy; (iii) Cardio-oncology: mitigating cancer therapy-related cardiac dysfunction in breast and gynaecological cancers, focusing on female-specific cardiotoxicity profiles, the importance of subclinical detection of cardiac dysfunction, and the implementation of cardioprotective strategies (ACE inhibitors, beta-blockers, SGLT2 inhibitors) during cardiotoxic treatments.<\/jats:p>\n                  <jats:p>Lifestyle interventions such as the DASH diet and exercise-based rehabilitation are highlighted as essential for maintaining cardiac reserve.<\/jats:p>","DOI":"10.1093\/ejhf\/xuag215","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:47:35Z","timestamp":1782992855000},"source":"Crossref","is-referenced-by-count":1,"title":["Prevention of heart failure in women: an expert consensus statement on sex-specific risk factors"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-962X","authenticated-orcid":false,"given":"Amina","family":"Rakisheva","sequence":"first","affiliation":[{"name":"Cardiology Department, Qonaev City Hospital , Almaty Region ,","place":["Kazakhstan"]},{"name":"International Medical School of the UIB , Faculty of Medicine, Almaty ,","place":["Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1024-1644","authenticated-orcid":false,"given":"Giandomenico","family":"Disabato","sequence":"additional","affiliation":[{"name":"University Cardiology, IRCCS Policlinico San Donato , Via Morandi 30, San Donato Milanese 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0786-7830","authenticated-orcid":false,"given":"Ana","family":"Abreu","sequence":"additional","affiliation":[{"name":"Institute of Environmental Health (ISAMB), Institute of Preventive Medicine and Public Health (IMPSP), CCUL, CAML, Faculty of Medicine (FMUL), University of Lisbon, Lisbon ,","place":["Portugal"]},{"name":"Centre of Cardiovascular Rehabilitation, Cardiology Department, University Hospital Santa Maria, ULSSM , Lisbon ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Attanasio","sequence":"additional","affiliation":[{"name":"University Cardiology, IRCCS Policlinico San Donato , Via Morandi 30, San Donato Milanese 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9341-117X","authenticated-orcid":false,"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Hannover Medical School , Hannover ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Becker","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Rhein-Maas Hospital , W\u00fcrselen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Callewaert","sequence":"additional","affiliation":[{"name":"Center for Medical Genetics, Ghent University Hospital, Ghent ,","place":["Belgium"]},{"name":"Department of Biomolecular Medicine, Ghent University, Ghent ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-8318","authenticated-orcid":false,"given":"Camil","family":"Castelo-Branco","sequence":"additional","affiliation":[{"name":"Clinic Institute of Gynecology, Obstetrics and Neonatology, Hospital Clinic, Barcelona ,","place":["Spain"]},{"name":"Faculty of Medicine-University of \u00a0 Barcelona, Barcelona, Spain"},{"name":"Institut d\u00b4Investigations Biomedicine August Pi i Sunyer (IDIBAPS) , Clinical Institute of Gynecology, Obstetrics and Neonatology, Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5365-7063","authenticated-orcid":false,"given":"Serenella","family":"Castelvecchio","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Prevention and Gender Medicine, I.R.C.C.S Policlinico San Donato , Via Morandi 30, San Donato Milanese 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8878-1507","authenticated-orcid":false,"given":"Julie","family":"De Backer","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Center for Medical Genetics, Ghent University Hospital, Ghent ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-6234","authenticated-orcid":false,"given":"Julia","family":"Grapsa","sequence":"additional","affiliation":[{"name":"Heart and Vascular Institute, Brigham and Women\u2019s Hospital, Mass General Brigham, Harvard Medical School , Boston, MA ,","place":["USA"]},{"name":"Department of Cardiology, Imperial College NHS Healthcare Trust, London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5666-8368","authenticated-orcid":false,"given":"Gianluigi","family":"Guida","sequence":"additional","affiliation":[{"name":"University Cardiology, IRCCS Policlinico San Donato , Via Morandi 30, San Donato Milanese 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina H","family":"Haugaa","sequence":"additional","affiliation":[{"name":"ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet , PO Box 4950 Nydalen, Oslo NO-0424 ,","place":["Norway"]},{"name":"Institute for Clinical Medicine, University of Oslo , Sognsvannsveien 9, Oslo 0373 ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9533-6951","authenticated-orcid":false,"given":"Kalliopi","family":"Keramida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, General Anti-Cancer Oncological Hospital Agios Savvas , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5852-1034","authenticated-orcid":false,"given":"Lis","family":"Neubeck","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular Health, School of Health and Social Care, Edinburgh Napier University , Sighthill Court, Edinburgh EH11 4BN ,","place":["UK"]},{"name":"Nursing, Faculty of Nursing and Midwifery, Wroclaw Medical University , Wroclaw 51-618 ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1713-6396","authenticated-orcid":false,"given":"Rossella E","family":"Nappi","sequence":"additional","affiliation":[{"name":"Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia , Pavia ,","place":["Italy"]},{"name":"Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS Policlinico San Matteo Foundation , Pavia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Price","sequence":"additional","affiliation":[{"name":"Royal Brompton Hospital, National Heart & Lung Institute, Imperial College , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3566-3467","authenticated-orcid":false,"given":"Vera","family":"Regitz-Zagrosek","sequence":"additional","affiliation":[{"name":"Senior Professor Charit\u00e9, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin and Berlin Institute of Health , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6770-3830","authenticated-orcid":false,"given":"Jolien W","family":"Roos-Hesselink","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC , Rotterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8272-0911","authenticated-orcid":false,"given":"Karen","family":"Sliwa","sequence":"additional","affiliation":[{"name":"Cape Heart Institute, Department of Cardiology & Medicine, University of Cape Town , Cape Town ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anzhela","family":"Soloveva","sequence":"additional","affiliation":[{"name":"Department of Hospital Therapy #2, Hospital Therapy Department \u21162, I.M. Sechenov First Moscow State Medical University , Moscow ,","place":["Russian Federation"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8197-8892","authenticated-orcid":false,"given":"Isabella","family":"Sudano","sequence":"additional","affiliation":[{"name":"University Hospital Zurich University Heart Center, Cardiology and University of Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Piepoli","sequence":"additional","affiliation":[{"name":"University Cardiology, IRCCS Policlinico San Donato , Via Morandi 30, San Donato Milanese 20097 ,","place":["Italy"]},{"name":"Dipartimento Scienze Biomediche Della Salute, Universit\u00e0 Degli Studi , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"2026072211015345900_xuag215-B1","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/eurheartj\/ehae868","article-title":"Sex-specific risk factors for new-onset heart failure: the PREVEND study at 25 years","volume":"46","author":"van Essen","year":"2024","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.101650","article-title":"Sex hormones and heart failure risk","volume":"4","author":"Ebong","year":"2025","journal-title":"JACC Adv"},{"key":"2026072211015345900_xuag215-B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmd.2025.100162","article-title":"Multitissue analysis of absorption, distribution, metabolism, and excretion gene expression: sex and age effects across human organ systems","volume":"53","author":"McCoy","year":"2025","journal-title":"Drug Metab Dispos"},{"key":"2026072211015345900_xuag215-B4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41569-022-00797-4","article-title":"Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes","volume":"20","author":"Regitz-Zagrosek","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"2026072211015345900_xuag215-B5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nrg2415","article-title":"Sex-specific genetic architecture of human disease","volume":"9","author":"Ober","year":"2008","journal-title":"Nat Rev Genet"},{"key":"2026072211015345900_xuag215-B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104459","article-title":"Sex-linked genetic mechanisms and atrial fibrillation risk","volume":"65","author":"Wren","year":"2022","journal-title":"Eur J Med Genet"},{"key":"2026072211015345900_xuag215-B7","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1093\/eurheartj\/ehaf193","article-title":"2025 ESC Guidelines for the management of cardiovascular disease and pregnancy","volume":"46","author":"De Backer","year":"2025","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B8","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr218","article-title":"ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)","volume":"32","author":"European Society of Gynecology (ESG)","year":"2011","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B9","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1161\/CIRCULATIONAHA.114.009029","article-title":"Cardiovascular physiology of pregnancy","volume":"130","author":"Sanghavi","year":"2014","journal-title":"Circulation"},{"key":"2026072211015345900_xuag215-B10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/uog.12296","article-title":"Altered maternal left ventricular contractility and function during normal pregnancy","volume":"41","author":"Estensen","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2026072211015345900_xuag215-B11","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1136\/heartjnl-2015-308946","article-title":"Cardiac adaption during pregnancy in women with congenital heart disease and healthy women","volume":"102","author":"Kampman","year":"2016","journal-title":"Heart"},{"key":"2026072211015345900_xuag215-B12","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1161\/CIRCULATIONAHA.113.002810","article-title":"Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease","volume":"128","author":"Pieper","year":"2013","journal-title":"Circulation"},{"key":"2026072211015345900_xuag215-B13","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/nrcardio.2015.172","article-title":"Use of medication for cardiovascular disease during pregnancy","volume":"12","author":"Pieper","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2026072211015345900_xuag215-B14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1161\/CIRCULATIONAHA.116.021594","article-title":"Pregnancy and the risk of aortic dissection or rupture: a cohort-crossover analysis","volume":"134","author":"Kamel","year":"2016","journal-title":"Circulation"},{"key":"2026072211015345900_xuag215-B15","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/ehjqcco\/qcac019","article-title":"Which risk score best predicts cardiovascular outcome in pregnant women with congenital heart disease?","volume":"9","author":"Bredy","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026072211015345900_xuag215-B17","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/eurheartj\/ehad003","article-title":"Pregnancy outcomes in women with heart disease: the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India","volume":"44","author":"Justin Paul","year":"2023","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B18","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/ehjqcco\/qcaf095","article-title":"Global real-world data on heart failure with reduced ejection fraction: challenges in optimization and sex disparities","volume":"11","author":"Attanasio","year":"2025","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026072211015345900_xuag215-B19","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B20","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B21","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026072211015345900_xuag215-B22","doi-asserted-by":"publisher","first-page":"132234","DOI":"10.1016\/j.ijcard.2024.132234","article-title":"Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC)","volume":"410","author":"Ramlakhan","year":"2024","journal-title":"Int J Cardiol"},{"key":"2026072211015345900_xuag215-B23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jacc.2018.10.075","article-title":"Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review","volume":"73","author":"Halpern","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026072211015345900_xuag215-B24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/eurheartj\/ehaf592","article-title":"Statin use in pregnancy and risk of congenital malformations: a Norwegian nationwide study","volume":"47","author":"Christensen","year":"2026","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B25","doi-asserted-by":"publisher","first-page":"e657","DOI":"10.1161\/CIR.0000000000001121","article-title":"Anesthetic care of the pregnant patient with cardiovascular disease: a scientific statement from the American Heart Association","volume":"147","author":"Meng","year":"2023","journal-title":"Circulation"},{"key":"2026072211015345900_xuag215-B26","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1093\/eurheartj\/ehad888","article-title":"A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry","volume":"45","author":"Jackson","year":"2024","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B27","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/eurheartj\/ehaf006","article-title":"Pregnancies in women after peri-partum cardiomyopathy: the global European Society of Cardiology EuroObservational Research Programme Peri-Partum Cardiomyopathy Registry","volume":"46","author":"Sliwa","year":"2025","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B28","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B29","doi-asserted-by":"publisher","first-page":"H661","DOI":"10.1152\/ajpheart.00202.2020","article-title":"Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia","volume":"319","author":"Qu","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026072211015345900_xuag215-B30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ijgo.12424","article-title":"Role of angiogenic factors in the pathogenesis and management of pre-eclampsia","volume":"141","author":"Ngene","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"2026072211015345900_xuag215-B31","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s40265-017-0823-0","article-title":"Aspirin for prevention of preeclampsia","volume":"77","author":"Atallah","year":"2017","journal-title":"Drugs"},{"key":"2026072211015345900_xuag215-B32","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association","volume":"79","author":"Garovic","year":"2022","journal-title":"Hypertension"},{"key":"2026072211015345900_xuag215-B33","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1001\/jama.2016.1869","article-title":"Association between hypertensive disorders of pregnancy and later risk of cardiomyopathy","volume":"315","author":"Behrens","year":"2016","journal-title":"JAMA"},{"key":"2026072211015345900_xuag215-B34","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021616","article-title":"Incident heart failure within the first and fifth year after delivery among women with hypertensive disorders of pregnancy and prepregnancy hypertension in a diverse population","volume":"10","author":"Malek","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026072211015345900_xuag215-B35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14093121","article-title":"Long-term cardiovascular risk and maternal history of Pre-eclampsia","volume":"14","author":"Palmiero","year":"2025","journal-title":"J Clin Med"},{"key":"2026072211015345900_xuag215-B36","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1161\/HYPERTENSIONAHA.120.15654","article-title":"Heart failure in women with hypertensive disorders of pregnancy: insights from the cardiovascular disease in Norway project","volume":"76","author":"Honigberg","year":"2020","journal-title":"Hypertension"},{"key":"2026072211015345900_xuag215-B37","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/ejhf.1493","article-title":"Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy","volume":"21","author":"Bauersachs","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026072211015345900_xuag215-B38","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1016\/S0140-6736(25)01451-5","article-title":"Peripartum cardiomyopathy","volume":"406","author":"Sliwa","year":"2025","journal-title":"Lancet"},{"key":"2026072211015345900_xuag215-B39","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000974","article-title":"Genetic risk of peripartum cardiomyopathy: an updated narrative review of the Pre-clinical and clinical literature","author":"Seidman","year":"2025","journal-title":"Cardiol Rev"},{"key":"2026072211015345900_xuag215-B40","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/ejhf.3246","article-title":"Multidisciplinary care of peripartum heart failure: a scientific statement of the Heart Failure Association of the ESC","volume":"26","author":"Rakisheva","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026072211015345900_xuag215-B41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jacc.2019.11.014","article-title":"Peripartum cardiomyopathy: JACC state-of-the-art review","volume":"75","author":"Davis","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026072211015345900_xuag215-B42","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1161\/CIR.0b013e3181db2f07","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy","volume":"121","author":"Elkayam","year":"2010","journal-title":"Circulation"},{"key":"2026072211015345900_xuag215-B43","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/eurheartj\/ehx355","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study","volume":"38","author":"Hilfiker-Kleiner","year":"2017","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B44","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/eurheartj\/ehae559","article-title":"Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registry","volume":"46","author":"van der Meer","year":"2025","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cardfail.2011.09.004","article-title":"Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator","volume":"18","author":"Saltzberg","year":"2012","journal-title":"J Card Fail"},{"key":"2026072211015345900_xuag215-B46","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1093\/humrep\/dei135","article-title":"ESHRE guideline for the diagnosis and treatment of endometriosis","volume":"20","author":"Kennedy","year":"2005","journal-title":"Hum Reprod"},{"key":"2026072211015345900_xuag215-B47","doi-asserted-by":"publisher","first-page":"e23130","DOI":"10.1096\/fj.202300907","article-title":"Endometriosis in the era of precision medicine and impact on sexual and reproductive health across the lifespan and in diverse populations","volume":"37","author":"Giudice","year":"2023","journal-title":"FASEB J"},{"key":"2026072211015345900_xuag215-B48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0889-8545(05)70302-8","article-title":"Epidemiology of endometriosis","volume":"24","author":"Eskenazi","year":"1997","journal-title":"Obstet Gynecol Clin North Am"},{"key":"2026072211015345900_xuag215-B49","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.fertnstert.2008.04.056","article-title":"High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners","volume":"92","author":"Meuleman","year":"2009","journal-title":"Fertil Steril"},{"key":"2026072211015345900_xuag215-B50","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoac009","article-title":"ESHRE guideline: endometriosis","volume":"2022","author":"Becker","year":"2022","journal-title":"Hum Reprod Open"},{"key":"2026072211015345900_xuag215-B51","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/1471-0528.16692","article-title":"Risk of cardiovascular outcomes among women with endometriosis in the United Kingdom: a retrospective matched cohort study","volume":"128","author":"Okoth","year":"2021","journal-title":"BJOG"},{"key":"2026072211015345900_xuag215-B52","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1161\/CIRCOUTCOMES.115.002224","article-title":"Endometriosis and risk of coronary heart disease","volume":"9","author":"Mu","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026072211015345900_xuag215-B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2025.114081","article-title":"Increased risk of cardiovascular disease in women with endometriosis: a systematic review and meta-analysis","volume":"312","author":"Saad","year":"2025","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026072211015345900_xuag215-B54","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1093\/eurheartj\/ehae563","article-title":"Endometriosis and long-term cardiovascular risk: a nationwide Danish study","volume":"45","author":"Havers-Borgersen","year":"2024","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B55","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.fertnstert.2011.05.090","article-title":"Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries","volume":"96","author":"Nnoaham","year":"2011","journal-title":"Fertil Steril"},{"key":"2026072211015345900_xuag215-B56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1477-7827-10-49","article-title":"The effects of oxidative stress on female reproduction: a review","volume":"10","author":"Agarwal","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"2026072211015345900_xuag215-B57","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/humupd\/dmv013","article-title":"Endometriosis: a high-risk population for major chronic diseases?","volume":"21","author":"Kvaskoff","year":"2015","journal-title":"Hum Reprod Update"},{"key":"2026072211015345900_xuag215-B58","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/aogs.70104","article-title":"Risk of cardiovascular disease and mortality among women with endometriosis: a systematic review and meta-analysis","volume":"105","author":"Cavadias","year":"2026","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2026072211015345900_xuag215-B59","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure: JACC state-of-the-art review","volume":"75","author":"Murphy","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026072211015345900_xuag215-B60","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1139\/cjpp-2024-0041","article-title":"Oral hormonal contraceptives and cardiovascular risks in females","volume":"102","author":"Bhullar","year":"2024","journal-title":"Can J Physiol Pharmacol"},{"key":"2026072211015345900_xuag215-B61","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/OGX.0000000000000718","article-title":"Cardiometabolic risk factors and benign gynecologic disorders","volume":"74","author":"AlAshqar","year":"2019","journal-title":"Obstet Gynecol Surv"},{"key":"2026072211015345900_xuag215-B62","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.molmed.2025.09.002","article-title":"Endometriosis and comorbidities: molecular mechanisms and clinical implications","volume":"32","author":"Petraglia","year":"2026","journal-title":"Trends Mol Med"},{"key":"2026072211015345900_xuag215-B63","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12905-025-03862-5","article-title":"Association between lipid accumulation product and visceral adiposity index with endometriosis: evidence from NHANES 1999\u20132006","volume":"25","author":"Ma","year":"2025","journal-title":"BMC Womens Health"},{"key":"2026072211015345900_xuag215-B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0317820","article-title":"The effectiveness and safety of physical activity and exercise on women with endometriosis: a systematic review and meta-analysis","volume":"20","author":"Xie","year":"2025","journal-title":"PLoS One"},{"key":"2026072211015345900_xuag215-B65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/humrep\/dead206","article-title":"Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions","volume":"39","author":"Vercellini","year":"2024","journal-title":"Hum Reprod"},{"key":"2026072211015345900_xuag215-B66","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1093\/eurheartj\/ehaf191","article-title":"2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee","volume":"46","author":"Bueno","year":"2025","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B67","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/humrep\/der396","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS)","volume":"27","author":"Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","year":"2012","journal-title":"Hum Reprod"},{"key":"2026072211015345900_xuag215-B68","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072211015345900_xuag215-B69","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"CLINICAL PRACTICE. Polycystic ovary syndrome","volume":"375","author":"McCartney","year":"2016","journal-title":"N Engl J Med"},{"key":"2026072211015345900_xuag215-B70","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.fertnstert.2022.03.008","article-title":"Cardiometabolic biomarkers in women with polycystic ovary syndrome","volume":"117","author":"van der Ham","year":"2022","journal-title":"Fertil Steril"},{"key":"2026072211015345900_xuag215-B71","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3390\/jcm13030698","article-title":"Possible effect of polycystic ovary syndrome (PCOS) on cardiovascular disease (CVD): an update","volume":"13","author":"Profili","year":"2024","journal-title":"J Clin Med"},{"key":"2026072211015345900_xuag215-B72","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa674","article-title":"Lipid management in patients with endocrine disorders: an endocrine society clinical practice guideline","volume":"105","author":"Newman","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072211015345900_xuag215-B73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249554","article-title":"Pharmacological approaches to controlling cardiometabolic risk in women with PCOS","volume":"21","author":"Cignarella","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026072211015345900_xuag215-B74","doi-asserted-by":"publisher","first-page":"e3369","DOI":"10.1210\/clinem\/dgab392","article-title":"Women with polycystic ovary syndrome have an increased risk of major cardiovascular events: a population study","volume":"106","author":"Berni","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072211015345900_xuag215-B75","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41598-023-50650-y","article-title":"Risk of cardiocerebrovascular diseases is increased in Korean women with polycystic ovary syndrome: a nationwide cohort study","volume":"14","author":"Ryu","year":"2024","journal-title":"Sci Rep"},{"key":"2026072211015345900_xuag215-B76","doi-asserted-by":"publisher","first-page":"zwaf351","DOI":"10.1093\/eurjpc\/zwaf351","article-title":"Polycystic ovarian syndrome and long-term risk of acute myocardial infarction and ischaemic stroke","author":"Havers-Borgersen","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"2026072211015345900_xuag215-B77","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/ejendo\/lvad067","article-title":"Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States","volume":"188","author":"Dwivedi","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"2026072211015345900_xuag215-B78","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s11883-023-01168-1","article-title":"Polycystic ovarian syndrome: a risk factor for cardiovascular disease","volume":"25","author":"Alvarez","year":"2023","journal-title":"Curr Atheroscler Rep"},{"key":"2026072211015345900_xuag215-B79","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1161\/CIRCULATIONAHA.123.065827","article-title":"Polycystic ovary syndrome fuels cardiovascular inflammation and aggravates ischemic cardiac injury","volume":"148","author":"Gao","year":"2023","journal-title":"Circulation"},{"key":"2026072211015345900_xuag215-B80","doi-asserted-by":"publisher","first-page":"614679","DOI":"10.3389\/fendo.2021.614679","article-title":"Impact of increased oxidative stress on cardiovascular diseases in women with polycystic ovary syndrome","volume":"12","author":"Duic\u0103","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026072211015345900_xuag215-B81","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.fertnstert.2025.08.033","article-title":"Association of polycystic ovary syndrome with atherosclerotic cardiovascular disease events","volume":"124","author":"Lee","year":"2025","journal-title":"Fertil Steril"},{"key":"2026072211015345900_xuag215-B82","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.3390\/nu15245069","article-title":"Moving beyond weight: a narrative review of the dietary and lifestyle management for reducing cardiometabolic risk in polycystic ovary syndrome (PCOS)","volume":"15","author":"Herbert","year":"2023","journal-title":"Nutrients"},{"key":"2026072211015345900_xuag215-B83","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.fertnstert.2022.03.009","article-title":"Polycystic ovary syndrome: a \u201crisk-enhancing\u201d factor for cardiovascular disease","volume":"117","author":"Guan","year":"2022","journal-title":"Fertil Steril"},{"key":"2026072211015345900_xuag215-B84","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/OAJC.S85543","article-title":"Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits","volume":"8","author":"de Melo","year":"2017","journal-title":"Open Access J Contracept"},{"key":"2026072211015345900_xuag215-B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2023.110310","article-title":"Comparison of estrogenic components used for hormonal contraception","volume":"130","author":"Stanczyk","year":"2024","journal-title":"Contraception"},{"key":"2026072211015345900_xuag215-B86","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.2174\/1381612827666210119104721","article-title":"Polycystic ovary syndrome: a contemporary clinical approach","volume":"27","author":"Bjeki\u0107-Macut","year":"2021","journal-title":"Curr Pharm Des"},{"key":"2026072211015345900_xuag215-B87","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1055\/s-0043-1777724","article-title":"Beyond counting sheep: exploring the link between polycystic ovary syndrome and sleep health","volume":"41","author":"Jafar","year":"2023","journal-title":"Semin Reprod Med"},{"key":"2026072211015345900_xuag215-B88","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/heartjnl-2020-317326","article-title":"Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction","volume":"107","author":"Sanderson","year":"2021","journal-title":"Heart"},{"key":"2026072211015345900_xuag215-B89","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1530\/EJE-18-0693","article-title":"Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study","volume":"180","author":"Kumarendran","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"2026072211015345900_xuag215-B90","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1161\/CIR.0000000000000912","article-title":"Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association","volume":"142","author":"El Khoudary","year":"2020","journal-title":"Circulation"},{"key":"2026072211015345900_xuag215-B91","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/eurheartj\/ehaa1044","article-title":"Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists","volume":"42","author":"Maas","year":"2021","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B92","doi-asserted-by":"publisher","first-page":"e033648","DOI":"10.1161\/JAHA.123.033648","article-title":"Menopausal vasomotor symptoms and subclinical atherosclerotic cardiovascular disease: a population-based study","volume":"13","author":"Nilsson","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026072211015345900_xuag215-B93","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0140-6736(23)02800-3","article-title":"Optimising health after early menopause","volume":"403","author":"Mishra","year":"2024","journal-title":"Lancet"},{"key":"2026072211015345900_xuag215-B94","doi-asserted-by":"publisher","first-page":"107784","DOI":"10.1016\/j.maturitas.2023.107784","article-title":"Early menopause is associated with increased risk of heart failure and atrial fibrillation: a systematic review and meta-analysis","volume":"176","author":"Liu","year":"2023","journal-title":"Maturitas"},{"key":"2026072211015345900_xuag215-B95","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1093\/eurheartj\/ehac364","article-title":"Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study","volume":"43","author":"Shin","year":"2022","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B96","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003769","article-title":"Association of age at menopause with incident heart failure: a prospective cohort study and meta-analysis","volume":"5","author":"Appiah","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2026072211015345900_xuag215-B97","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/GME.0000000000000138","article-title":"Age at menopause and incident heart failure: the Multi-Ethnic Study of Atherosclerosis","volume":"21","author":"Ebong","year":"2014","journal-title":"Menopause"},{"key":"2026072211015345900_xuag215-B98","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1038\/s41598-024-57058-2","article-title":"Early menopause is associated with abnormal diastolic function and poor clinical outcomes in women with suspected angina","volume":"14","author":"Bae","year":"2024","journal-title":"Sci Rep"},{"key":"2026072211015345900_xuag215-B99","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1152\/japplphysiol.00467.2025","article-title":"Vascular function in women with heart failure with preserved ejection fraction: a mismatch beyond diastole","volume":"139","author":"Carlini","year":"2025","journal-title":"J Appl Physiol (1985)"},{"key":"2026072211015345900_xuag215-B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00021.2015","article-title":"Mechanistic pathways of sex differences in cardiovascular disease","volume":"97","author":"Regitz-Zagrosek","year":"2017","journal-title":"Physiol Rev"},{"key":"2026072211015345900_xuag215-B101","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.118.034271","article-title":"Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction","volume":"138","author":"Beale","year":"2018","journal-title":"Circulation"},{"key":"2026072211015345900_xuag215-B102","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jacc.2019.12.049","article-title":"Menopause-related estrogen decrease and the pathogenesis of HFpEF: JACC review topic of the week","volume":"75","author":"Sabbatini","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026072211015345900_xuag215-B103","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/GME.0000000000000342","article-title":"Association of menopause age and N-terminal pro brain natriuretic peptide: the Multi-Ethnic Study of Atherosclerosis","volume":"22","author":"Ebong","year":"2015","journal-title":"Menopause"},{"key":"2026072211015345900_xuag215-B104","doi-asserted-by":"publisher","first-page":"e028849","DOI":"10.1161\/JAHA.122.028849","article-title":"Protein biomarkers of early menopause and incident cardiovascular disease","volume":"12","author":"Ramirez","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026072211015345900_xuag215-B105","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0140-6736(25)01393-5","article-title":"Prioritising the primary prevention of heart failure","volume":"406","author":"Khan","year":"2025","journal-title":"Lancet"},{"key":"2026072211015345900_xuag215-B106","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1093\/eurheartj\/ehad472","article-title":"Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society","volume":"44","author":"Roeters van Lennep","year":"2023","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B107","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S2213-8587(22)00076-6","article-title":"Menopause: a cardiometabolic transition","volume":"10","author":"Nappi","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072211015345900_xuag215-B108","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3945\/ajcn.116.143016","article-title":"Dietary patterns and cardiometabolic and endocrine plasma biomarkers in US women","volume":"105","author":"AlEssa","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"2026072211015345900_xuag215-B109","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/01.CIR.103.1.32","article-title":"Women's Healthy Lifestyle Project: a randomized clinical trial: results at 54 months","volume":"103","author":"Kuller","year":"2001","journal-title":"Circulation"},{"key":"2026072211015345900_xuag215-B110","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ijcard.2008.08.001","article-title":"Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis","volume":"138","author":"Petretta","year":"2010","journal-title":"Int J Cardiol"},{"key":"2026072211015345900_xuag215-B111","doi-asserted-by":"publisher","first-page":"b2376","DOI":"10.1136\/bmj.b2376","article-title":"The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials","volume":"338","author":"Brugts","year":"2009","journal-title":"BMJ"},{"key":"2026072211015345900_xuag215-B112","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1161\/CIR.0000000000000625","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"2026072211015345900_xuag215-B113","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1016\/j.jacc.2020.11.021","article-title":"The global burden of cardiovascular diseases and risks: a compass for global action","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026072211015345900_xuag215-B114","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/13697137.2023.2256673","article-title":"A disease of her own? Unique features of heart failure in women","volume":"27","author":"Spacht","year":"2024","journal-title":"Climacteric"},{"key":"2026072211015345900_xuag215-B115","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/PPO.0000000000000591","article-title":"Menopausal hormone replacement therapy and reduction of all-cause mortality and cardiovascular disease: it is about time and timing","volume":"28","author":"Hodis","year":"2022","journal-title":"Cancer J"},{"key":"2026072211015345900_xuag215-B116","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/GME.0000000000000590","article-title":"Venous thromboembolism and cardiovascular disease complications in menopausal women using transdermal versus oral estrogen therapy","volume":"23","author":"Simon","year":"2016","journal-title":"Menopause"},{"key":"2026072211015345900_xuag215-B117","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026072211015345900_xuag215-B118","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.14.04155","article-title":"Global burden of gynaecological cancers in 2022 and projections to 2050","volume":"14","author":"Zhu","year":"2024","journal-title":"J Global Health"},{"key":"2026072211015345900_xuag215-B119","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17132198","article-title":"Cardiotoxicity in elderly breast cancer patients","volume":"17","author":"Keramida","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2026072211015345900_xuag215-B120","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1161\/CIR.0000000000000556","article-title":"Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association","volume":"137","author":"Mehta","year":"2018","journal-title":"Circulation"},{"key":"2026072211015345900_xuag215-B121","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/JCO.1997.15.4.1544","article-title":"Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience","volume":"15","author":"Krischer","year":"1997","journal-title":"J Clin Oncol"},{"key":"2026072211015345900_xuag215-B122","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1080\/10428190802140873","article-title":"Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapy","volume":"49","author":"Myrehaug","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"2026072211015345900_xuag215-B123","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13293-018-0198-2","article-title":"Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity","volume":"9","author":"Meiners","year":"2018","journal-title":"Biol Sex Differ"},{"key":"2026072211015345900_xuag215-B124","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1200\/JCO.21.02377","article-title":"Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials","volume":"40","author":"Unger","year":"2022","journal-title":"J Clin Oncol"},{"key":"2026072211015345900_xuag215-B125","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023852","article-title":"Inequity in cardio-oncology: identifying disparities in cardiotoxicity and links to cardiac and cancer outcomes","volume":"10","author":"Ohman","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026072211015345900_xuag215-B126","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40959-025-00311-y","article-title":"Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213)","volume":"11","author":"Sutton","year":"2025","journal-title":"Cardiooncology"},{"key":"2026072211015345900_xuag215-B127","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11082286","article-title":"Racial disparity in anthracycline-induced cardiotoxicity in breast cancer patients","volume":"11","author":"Balaji","year":"2023","journal-title":"Biomedicines"},{"key":"2026072211015345900_xuag215-B128","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1200\/JCO.2018.78.3290","article-title":"Sex differences in efficacy and toxicity of systemic treatments: an undervalued issue in the era of precision oncology","volume":"36","author":"\u00d6zdemir","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026072211015345900_xuag215-B129","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/annonc\/mdz414","article-title":"Gender medicine and oncology: report and consensus of an ESMO workshop","volume":"30","author":"Wagner","year":"2019","journal-title":"Ann Oncol"},{"key":"2026072211015345900_xuag215-B130","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.597788","article-title":"Genome-wide sex and gender differences in cancer","volume":"10","author":"Lopes-Ramos","year":"2020","journal-title":"Front Oncol"},{"key":"2026072211015345900_xuag215-B131","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement","volume":"43","author":"Herrmann","year":"2022","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B132","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1161\/CIRCULATIONAHA.116.025434","article-title":"Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast cancer","volume":"135","author":"Saiki","year":"2017","journal-title":"Circulation"},{"key":"2026072211015345900_xuag215-B133","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaccao.2022.01.099","article-title":"Lifestyle and cardiovascular risk factors associated with heart failure subtypes in postmenopausal breast cancer survivors","volume":"4","author":"Reding","year":"2022","journal-title":"JACC CardioOncol"},{"key":"2026072211015345900_xuag215-B134","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1002\/ejhf.70005","article-title":"Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology","volume":"27","author":"Keramida","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026072211015345900_xuag215-B135","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1002\/ejhf.3412","article-title":"The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology","volume":"26","author":"Keramida","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026072211015345900_xuag215-B136","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B137","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10549-023-06997-x","article-title":"Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer","volume":"201","author":"Rillamas-Sun","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"2026072211015345900_xuag215-B138","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041278","article-title":"Heart failure association-international cardio-oncology society risk score validation in HER2-positive breast cancer","volume":"12","author":"Cronin","year":"2023","journal-title":"J Clin Med"},{"key":"2026072211015345900_xuag215-B139","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1093\/eurheartj\/ehae574","article-title":"Strain surveillance during chemotherapy to improve cardiovascular outcomes: the SUCCOUR-MRI trial","volume":"45","author":"Marwick","year":"2024","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B140","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/bcp.13008","article-title":"Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity","volume":"82","author":"Aminkeng","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"2026072211015345900_xuag215-B141","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14041286","article-title":"Genetic background in patients with cancer therapy-induced cardiomyopathy","volume":"14","author":"Fazzini","year":"2025","journal-title":"J Clin Med"},{"key":"2026072211015345900_xuag215-B142","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194665","article-title":"Pharmacogenomics for prediction of cardiovascular toxicity: landscape of emerging data in breast cancer therapies","volume":"14","author":"Altena","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026072211015345900_xuag215-B143","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.118.037934","article-title":"Genetic variants associated with cancer therapy-induced cardiomyopathy","volume":"140","author":"Garcia-Pavia","year":"2019","journal-title":"Circulation"},{"key":"2026072211015345900_xuag215-B144","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17091562","article-title":"Heart and left anterior descending coronary artery (LAD) exposure from hypo-fractionated whole breast radiotherapy with a prone setup","volume":"17","author":"Gregucci","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2026072211015345900_xuag215-B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103993","article-title":"Surface-based deep inspiration breath-hold radiotherapy in left-sided breast cancer: final results from the SAVE-HEART study","volume":"9","author":"Sch\u00f6necker","year":"2024","journal-title":"ESMO Open"},{"key":"2026072211015345900_xuag215-B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.tipsro.2023.100219","article-title":"ESTRO-ACROP guideline for positioning, immobilisation and setup verification for local and loco-regional photon breast cancer irradiation","volume":"28","author":"Mast","year":"2023","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"2026072211015345900_xuag215-B147","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/eurheartj\/ehaf100","article-title":"Cardio-oncology rehabilitation and exercise: evidence, priorities, and research standards from the ICOS-CORE working group","volume":"46","author":"Adams","year":"2025","journal-title":"Eur Heart J"},{"key":"2026072211015345900_xuag215-B148","doi-asserted-by":"publisher","first-page":"e997","DOI":"10.1161\/CIR.0000000000000679","article-title":"Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American Heart Association","volume":"139","author":"Gilchrist","year":"2019","journal-title":"Circulation"},{"key":"2026072211015345900_xuag215-B149","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pcad.2024.02.002","article-title":"Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast cancer chemotherapy: the ONCORE randomized controlled trial","volume":"85","author":"D\u00edaz-Balboa","year":"2024","journal-title":"Prog Cardiovasc Dis"},{"key":"2026072211015345900_xuag215-B150","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.29104","article-title":"Participation of women in cardiovascular trials from 2017 to 2023: a systematic review","volume":"8","author":"Rivera","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026072211015345900_xuag215-B151","doi-asserted-by":"publisher","DOI":"10.2196\/63964","article-title":"Application of artificial intelligence in cardio-oncology imaging for cancer therapy-related cardiovascular toxicity: systematic review","volume":"11","author":"Mushcab","year":"2025","journal-title":"JMIR Cancer"},{"key":"2026072211015345900_xuag215-B152","doi-asserted-by":"publisher","DOI":"10.2196\/63455","article-title":"An interdisciplinary ecosystem for the prevention of cardiotoxicity in older patients with breast cancer: protocol for a prospective and multicentric study","volume":"14","author":"Sacco","year":"2025","journal-title":"JMIR Res Protoc"},{"key":"2026072211015345900_xuag215-B153","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1223660","article-title":"Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals","volume":"10","author":"Bisceglia","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026072211015345900_xuag215-B154","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1095251","article-title":"Long-term and real-life incidence of cancer therapy-related cardiovascular toxicity in patients with breast cancer: a Swedish cohort study","volume":"13","author":"Hubbert","year":"2023","journal-title":"Front Oncol"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article-pdf\/doi\/10.1093\/ejhf\/xuag215\/68690732\/xuag215.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article-pdf\/doi\/10.1093\/ejhf\/xuag215\/68690732\/xuag215.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:01:59Z","timestamp":1784732519000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article\/doi\/10.1093\/ejhf\/xuag215\/8724071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":154,"URL":"https:\/\/doi.org\/10.1093\/ejhf\/xuag215","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"article-number":"xuag215"}}